These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33816613)

  • 1. LncRNA RBM5-AS1 Promotes Osteosarcoma Cell Proliferation, Migration, and Invasion.
    Deng B; Pan R; Ou X; Wang T; Wang W; Nie Y; Chen H
    Biomed Res Int; 2021; 2021():5271291. PubMed ID: 33816613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of long noncoding RNA SBF2-AS1 inhibits proliferation, migration and invasion and contributes to apoptosis in osteosarcoma cells by upregulating microRNA-30a to suppress FOXA1 expression.
    Dai JH; Huang WZ; Li C; Deng J; Lin SJ; Luo J
    Cell Cycle; 2019 Oct; 18(20):2727-2741. PubMed ID: 31432728
    [No Abstract]   [Full Text] [Related]  

  • 3. LncRNA DSCAM-AS1 promoted cell proliferation and invasion in osteosarcoma by sponging miR-101.
    Yu CL; Xu NW; Jiang W; Zhang H; Ma Y
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7709-7717. PubMed ID: 32744697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. lncRNA GAS8-AS1 downregulates lncRNA UCA1 to inhibit osteosarcoma cell migration and invasion.
    Zha Z; Han Q; Liu W; Huo S
    J Orthop Surg Res; 2020 Feb; 15(1):38. PubMed ID: 32013985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA FOXD2-AS1 knockdown inhibits the resistance of human osteosarcoma cells to cisplatin by inhibiting miR-143 expression.
    Zhang QQ; Xu SL; Ding C; Ma CC; Yuan TS; Hua CC; Wang XH
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):678-686. PubMed ID: 33577022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA ADPGK-AS1 regulated cell proliferation, invasion, migration and apoptosis via targeting miR-542-3p in osteosarcoma.
    Luo XF; Wu XJ; Wei X; Wang AG; Wang SH; Wang JL
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8751-8760. PubMed ID: 31696461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA ADIRF antisense RNA 1 upregulates insulin receptor substrate 1 to decrease the aggressiveness of osteosarcoma by sponging microRNA-761.
    Xu L; Tan Y; Xu F; Zhang Y
    Bioengineered; 2022 Feb; 13(2):2028-2043. PubMed ID: 35030964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXP4-AS1 participates in the development and progression of osteosarcoma by downregulating LATS1 via binding to LSD1 and EZH2.
    Yang L; Ge D; Chen X; Qiu J; Yin Z; Zheng S; Jiang C
    Biochem Biophys Res Commun; 2018 Aug; 502(4):493-500. PubMed ID: 29859193
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Luo Y; Tao H; Jin L; Xiang W; Guo W
    Cancer Biother Radiopharm; 2020 Feb; 35(1):58-65. PubMed ID: 31724892
    [No Abstract]   [Full Text] [Related]  

  • 10. Long Noncoding RNA SERTAD2-3 Inhibits Osteosarcoma Proliferation and Migration by Competitively Binding miR-29c.
    Zhang Z; Liu J; Wu Y; Zhao X; Hao Y; Wang X; Xue C; Wang Y; Zhang R; Zhang X
    Genet Test Mol Biomarkers; 2020 Feb; 24(2):67-72. PubMed ID: 31999493
    [No Abstract]   [Full Text] [Related]  

  • 11. Long Noncoding RNA HNF1A-AS1 Regulates Osteosarcoma Advancement Through Modulating the miR-32-5p/HMGB1 Axis.
    Lou P; Ding T; Zhan X
    Cancer Biother Radiopharm; 2021 May; 36(4):371-381. PubMed ID: 32706998
    [No Abstract]   [Full Text] [Related]  

  • 12. LncRNA SOX21-AS1 Promotes the Growth and Invasiveness of Osteosarcoma Cells Through miR-7-5p/IRS2 Regulatory Network.
    Chen H; Chen J
    Arch Med Res; 2021 Apr; 52(3):294-303. PubMed ID: 33341286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA MNX1-AS1 promoted osteosarcoma proliferation and invasion via inhibiting KISS1.
    Zhang YX; Cui HX; Liu L; Yi GK
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6045-6052. PubMed ID: 31364121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a.
    Li C; Zhang S; Qiu T; Wang Y; Ricketts DM; Qi C
    Cancer Biol Ther; 2019; 20(4):413-422. PubMed ID: 30489194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA BE503655 inhibits osteosarcoma cell proliferation, invasion/migration via Wnt/β-catenin pathway.
    Huang Q; Shi SY; Ji HB; Xing SX
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31316000
    [No Abstract]   [Full Text] [Related]  

  • 16. Long noncoding RNA CRNDE functions as a diagnostic and prognostic biomarker in osteosarcoma, as well as promotes its progression via inhibition of miR-335-3p.
    Yu Y; Wang L; Li Z; Zheng Y; Shi Z; Wang G
    J Biochem Mol Toxicol; 2021 May; 35(5):e22734. PubMed ID: 33522065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA AFAP1-AS1 promotes tumorigenesis and epithelial-mesenchymal transition of osteosarcoma through RhoC/ROCK1/p38MAPK/Twist1 signaling pathway.
    Shi D; Wu F; Mu S; Hu B; Zhong B; Gao F; Qing X; Liu J; Zhang Z; Shao Z
    J Exp Clin Cancer Res; 2019 Aug; 38(1):375. PubMed ID: 31443665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. lncRNA RBM5-AS1 promotes cell proliferation and invasion by epigenetically silencing miR-132/212 in hepatocellular carcinoma cells.
    Mu JY; Tian JX; Chen YJ
    Cell Biol Int; 2021 Nov; 45(11):2201-2210. PubMed ID: 34019714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of long non-coding RNA ITGB2-AS1 inhibits osteosarcoma proliferation and metastasis by repressing Wnt/β-catenin signalling and predicts favourable prognosis.
    Dai J; Xu LJ; Han GD; Jiang HT; Sun HL; Zhu GT; Tang XM
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S783-S790. PubMed ID: 30260245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role and clinical significance of long noncoding RNA zinc finger E-box-binding homeobox two antisense RNA 1 in promoting osteosarcoma cancer cell proliferation, inhibiting apoptosis and increasing migration by regulating miR-145.
    Zhou Y; Feng D; Gu X; Gao A; Liu Y
    Anticancer Drugs; 2021 Feb; 32(2):168-177. PubMed ID: 32826416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.